The Latest Breaking News from the Food and Drug Administration

The Food and Drug Administration (FDA) approved a drug to help protect infants from respiratory syncytial virus (RSV). The medication, given as a single-dose injection prior to or during RSV season, is a monoclonal antibody. It is intended for babies born during or entering their first RSV season and for…

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

The Food and Drug Administration rejected a high-dose version of Regeneron's eye drug Eylea on Tuesday, leading REGN stock to crumble.

The Associated Press has found that the Food and Drug Administration can't keep up with a flood of illegal disposable e-cigarettes from China

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.

The warning from the Food and Drug Administration is the latest attempt by regulators to crack down on illegal disposable vapes that have poured into U.S. stores in recent years.